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Human cytomegalovirus (HCMV)
populations. In certain clinical settings it is the reactivation of the pre-existing latent infection in the 25 host that poses the health risk. The prevailing view of HCMV latency was that the virus was 26 essentially quiescent in myeloid progenitor cells and that terminal differentiation resulted in the 27 initiation of the lytic lifecycle and reactivation of infectious virus. However, our understanding of 28 HCMV latency and reactivation at the molecular level has been greatly enhanced through recent 29 advancements in systems biology approaches to perform global analyses of both experimental and 30 natural latency. These approaches, in concert with more classical reductionist experimentation, are 31 furnishing researchers with new concepts in cytomegalovirus latency and suggest that latent 32 infection is far more active than first thought. In this review we will focus on new studies that 33 suggest that distinct sites of cellular latency could exist in the human host which, when coupled with 34 recent observations that report different transcriptional programmes within cells of the myeloid 35 lineage, argues for multiple latent phenotypes that could impact differently on the biology of this 36 virus in vivo. Finally, we will also consider how the biology of the host cell where the latent infection 37 persists further contributes to the concept of a spectrum of latent phenotypes in multiple cell types 38 which can be exploited by the virus. The herpesvirus human cytomegalovirus (HCMV) represents a very common infection exhibiting a 45 seroprevalence of 0-100% depending on socioeconomic status. Primary infection of healthy 46 individuals with HCMV is usually asymptomatic but results in the establishment of a lifelong infection 47 of the host [1] . HCMV is also highly immunogenic with infection and persistence leaving a large 48 indelible mark on both CD4 + and CD8 + T cell compartments of seropositive individuals [2] . In stark 49 contrast with the asymptomatic infection of healthy individuals, congenital infection or infection of 50 immunocompromised patients can result in significant morbidity and mortality [1, 3, 4] . As well as 51 primary infection, a profound disease burden is also associated with the reactivation of infectious 52 virus within latently infected individuals -particularly in allograft bone marrow transplant patients 53 [5] . Similarly, a 2011 meta-analysis of congenital HCMV infections in the US (between 1988-1994) 54 estimated that only 25 % of HCMV cases found at birth resulted from maternal primary infection 55 during pregnancy which highlights the importance of understanding the impact of non-primary 56 infections: i.e. re-infection and reactivation from latency in seropositive mothers [6] . 57 58 HCMV latency and reactivation represents both clinical problem and challenging academic riddle. 59
Significant research efforts have been directed towards developing an understanding of the 60 mechanisms that are involved in the establishment and maintenance of viral latency as well as the 61 fundamental principles that govern the reactivation of latent virus. These strategies have involved 62 studies in primary human tissue and cell culture models, as well as using animal model systems of 63 CMV which, all told, have generated a fascinating insight into the enigmatic problem of latency. 64
From the beginnings of understanding the cellular basis of latency onto more recent studies that 65 have utilised powerful systems biology approaches to probe the molecular details the story of HCMV 66 latency and reactivation is unravelling. In this review we will focus on the recent identification of a 67 number of viral and cellular gene products that are active in latently infected cells -including the 68 detection of both viral and cellular non-coding RNAs -and how they contribute to the latent 69 phenotype. Furthermore, we will consider how the identification of these functions impacts on our 70 understanding of HCMV latency with particular emphasis on the concept that multiple latent 71 phenotypes may exist within the host. Finally, we will illustrate how these new insights resonate 72 with studies in the alpha and gamma herpes virus families through shared viral and cellular functions 73 or mechanisms that help govern the latent state. 74
75
Keep your friends close... 76
A key characteristic of human herpesvirus infection is the ability to establish a lifelong latent 77 infection in the host. The establishment of herpes virus latency can occur in multiple cell types with 78 the alpha herpesviruses exhibiting a neuronal tropism whereas the cells of the haematopoietic 79 system represent important reservoirs for the beta and gamma herpesviruses. Although the cellular 80 identity of the latently infected cell can vary, latency at a molecular level is characterised by overall 81 suppression of viral lytic gene expression attributable to epigenetic regulation via histone 82 modification machinery, a very limited but specific transcriptional profile during latency, and a 83 responsiveness to host derived cues to exit latency and re-enter the lytic lifecycle [7] [8] [9] . 84 85 Similarly, at a molecular level, the mechanisms governing latency/persistence during murine CMV 86 (MCMV) infection appear to have resonance with studies of HCMV also -if not least when 87 considering the molecular mechanisms that dictate the regulation of major immediate early (MIE) 88 gene expression required for full lytic infection [10] . In contrast, a compelling comparative narrative 89 at the cellular level is less clear [10] . Whereas HCMV latency in the haematopoietic cell lineage well 90 established the same is not true of MCMV where studies of latency have focused on the role of 91 endothelial cells of a number of organs. Of course, it is entirely possible that the nature of studying 92 HCMV in the human host directly renders it difficult to address whether other cell types, alongside 93 cells of the haematopoietic system, are also sites of viral latency (Figure 1 ). For instance, attempts to 94 study human endothelial cells have proven somewhat inconclusive. Although HCMV genomes could 95 not be detected in endothelial cells isolated from saphenous vein tissue [11] , in vitro studies suggest 96 that subsets of endothelial cells -for instance aortic -could support a latent or at least a persistent, 97 non-lytic, infection [12] . Thus, the vascular origin of the endothelial cells could be important and 98
suggests that an analysis of circulating endothelial cell progenitors in the peripheral blood may 99 reveal a further site of HCMV latency and represents a tractable question to address. 100 101 Finally, it is important to recognise that multiple sites of viral latency could exist in the host. 102
Although many studies of MCMV latency focus on endothelial cells this does not preclude myeloid 103 cells as also being important. The detection of MCMV genomes in bone marrow and macrophages 104 has been observed and, importantly, these genomes can be reactivated [13] . Recent work analysing 105 MCMV infection suggested that MCMV hijacked the function of a subset of monocytic cells 106 ('patrolling monocytes') to promote viral dissemination [14] . The inference from this study is that 107 the immuno-privileged phenotype of the patrolling monocytes exploited for dissemination could 108 also be important for the establishment of long term persistence in the host. Although a preceding 109 study reported that patrolling monocytes were not important sites of MCMV reactivation, this study 110 focused on liver tissue and thus it is plausible that specific cell types contribute to reactivation in 111 discrete organs within the host and, secondly, may point towards a specific role for monocytes in the 112 seeding of MCMV latency in endothelial cells rather than as a site of long term latency themselves. Furthermore, resolving the differences between the distinct types of neuronal cells and how they 128 respond to reactivation stimuli could have wider impact on our understanding of HCMV reactivation 129 in multiple cell types -particularly given that the recent study [17] identified multiple blocks to 130 reactivation of infectious virus which resonates with studies of latency in myeloid cells [19, 20] . 131
However, interrogating these sites ex vivo is somewhat more challenging than the haematopoietic 132 system due to almost prohibitive access to the material required to perform the same analyses that 133 have defined the cells of the haematopoietic lineage as sites of HCMV latency. 134
135
The silent virus? 136
Perhaps the most significant advance in our recent understanding of HCMV latency is the 137 contribution of viral functions to this process -an area of study which, until recently, was in contrast 138 to the arguably much better defined patterns of gene expression observed with the alpha and 139 gamma herpesvirus subfamilies. The most intensively studied of all latent transcripts is the latency 140 associated transcript (LAT) of herpes simplex virus -acting as a non-coding RNA that, once subjected 141 to RNA processing, exerts an impressive number of reported functions including anti-apoptotic 142 effects, heterochromatic modification of histones as well as the generation of virally encoded miRNA 143 species with the potential to regulate viral and cellular gene expression [8, [21] [22] [23] . Similarly, for the 144 gammaherpes subfamily, untranslated RNAs have been identified during viral latency [24, 25] . It is of 145 note that a number of alternate transcriptional programmes have been described for EBV based 146 upon the analysis of transformed cell lines but, at least in long-term healthy carriers, the detection 147 of lymphocytes expressing EBV proteins is quite sporadic and is usually restricted to EBNA-1 and 148 LMP-2A positive cells [26, 27] . Evidently, the expression of non-coding RNAs during latency provides 149 a sophisticated mechanism for modulating the host cell environment without attracting an immune 150 response against the latently infected cell. 151
152
Does HCMV express functional untranslated RNAs during latency? 153
There are now a number of studies that have reported latent gene expression in various 154 experimental latent systems [28] [29] [30] [31] [32] [33] a number of which have also been detected in natural latency 155 [29, 32, [34] [35] [36] [37] . However, the most recent addition to this increasing repertoire of genes expressed 156 during latency was provided by a provocative study utilising an RNAseq analysis of HCMV 157 transcription during both experimental and natural latency [33] . Amongst these were non-coding 158
RNAs including beta 2.7 which was a predominant transcript in naturally latent CD14+ cells 159 (interestingly, a transcript that was not identified in the first studies that showed monocytes as a site 160 of persistence in vivo [19] ) and experimentally latent CD34+ cells (exhibiting between 20-30x the 161 number of 'reads' detected for UL138 -an accepted latent gene product [35] ). Similarly, beta 2.7 162 was detected in CD34+ cells isolated from the peripheral blood of healthy volunteers although at 163 relatively lower levels than observed for UL138. Indeed it is interesting to note whilst overlap was 164 observed with the experimental and natural latency transcriptional profiles they are not equivalent. The regulation of the MIEP during latency involves multi-faceted integration of viral and cellular 217 functions that act concomitantly to generate a phenotype that promotes latent infection. However, 218
it is now clear that a discrete set of protein coding transcripts is expressed during latency [29, 32, 34-219 37] . A number of these gene products are involved in the manipulation of the cellular environment 220 to re-direct the immune response (e.g. US28 [53] contribute to the immune-suppressive phenotype generated in, and around the microenvironment 226 of, a latently infected cell in vitro [59] [60] [61] . Furthermore, it is hypothesised that LAvIL10 and cIL10 227 may act in unison to drive a more expansive range of outcomes from providing protection from cell 228 death stimuli, driving latent gene expression to propagating the unique cellular miRNA landscape 229 observed in latently infected CD34+ cells [51, 62, 63] . 230 231 The repertoire of latent functions was expanded by, perhaps, the most provocative observation in 232 the recent RNAseq study regarding the detection of IE1 sequences in the naturally latent CD34+ cells 233 analysed -initially suggesting that the MIE region is active in the cells analysed in this study [33] . The 234 reported detection of UL123 RNA was discrepant with a number of previous studies that show major 235 IE gene expression is undetectable in the cells of naturally latent individuals [19, 29, 40, 64] . 236
Importantly, more recent evidence at least addresses these concerns in part. A protein product 237 arising from exon 4 of the MIE (IE1ex4) is detectable in CD34+ cells and that the expression of the 238 coding transcript is under the control of a promoter distinct from the MIEP [65] . It was speculated 239 that this region was important for maintenance of the viral genome during latency with the IE1ex4 240 gene product having important tethering functions analogous to those observed with KSHV gene 241 product LANA [66] . Importantly, these studies also suggested evidence for latent replication mechanism that drives the switch in the chromatin phenotype. However, if we reason that the MIEP 296 behaves akin to a cellular inflammatory promoter -and, in essence, consider the MIEP as another 297 genetic element influenced by the same mechanisms that control eukaryotic gene expression -we 298 can begin to unravel its regulation. Firstly, the MIEP is responsive to a number of inflammatory 299 stimuli [85] [86] [87] and, furthermore, HCMV reactivation and disease is associated with highly 300 inflammatory environments [78, 88, 89] . Secondly, the reactivation of HCMV IE gene expression is 301 seen efficiently in dendritic cell types in vitro [40, 77, 87 , 90] -a cell type that is a prodigious 302 producer of inflammatory cytokines following stimulation. In itself this seems a minor link except 303 when we consider the activation of inflammation requires the de-methylation and subsequent 304 acetylation of histones bound to these cellular promoters and that this can occur in a mitogen 305 activated kinase, NF-kB and CREB dependent manner [91] . Our own recent work has illustrated that 306 the activation of ERK-MAPK signalling in DCs plays an important role in HCMV reactivation [48, 87] 307 and built on previous studies suggesting that the CREB transcription factor was an important 308 mediator of viral reactivation [92, 93] . Furthermore, studies using experimentally latent cell lines as 309 well as clinical data suggest enhanced NF-kB signalling correlates with HCMV reactivation [85, 89, 310 94]. All these data would be consistent with the hypothesis that the HCMV MIEP is mimicking the 311 promoters of cell-encoded inflammatory genes. 312 and thus it is possible latent functions contribute to a phenotype more conducive for pro-389 reactivation stimuli. This in itself would be consistent with the common theme that pathogens hijack 390 signalling pathways by isolating and re-directing the facets that are beneficial away from the non-391 beneficial aspects. 392 393 However, as it currently stands, the study of higher order chromatin structure and the control of 394 either viral or cellular gene expression are potentially approaching an impasse. Current techniques 395 rely on global analyses of cell populations that are fixed in time which, due to the low throughput 396 nature, can only analyse relatively large time frames. As such, it cannot be determined whether a 397 number of observations play a functional role or are bystander effects that are essentially passive in 398 the process. The ability to image this on a single cell scale and watch changes in real time will 399 massively impact on this. A recent study elegantly demonstrated that RNA Pol II activation is indeed 400 regulated by histone acetylation [115] suggesting that the study of chromatin dynamics at the single 401 cell scale is possible. Applying this to study the regulation of the MIEP in real time will substantially 402 illuminate our understanding of the factors directly regulating viral -and, more broadly, eukaryotic -403 gene expression. However, the application of this approach for studying HCMV will additionally rely 404 heavily on the future development of new techniques that facilitate the isolation and enrichment of 405 HCMV genome positive cells -a technical hurdle that has not yet been overcome. 406
407
Fighting on multiple fronts 408
An incorrect assumption would be that there is one de facto mechanism required for HCMV 409 reactivation. This seems unlikely to be the case especially if the concept of a single latency 410 phenotype is becoming less applicable. The reactivation of HCMV in differentiated myeloid cells has 411 been reported following the stimulation of multiple progenitor cell types under a variety of 412 inflammatory conditions [31, 40, 64, 78, 79, 87] . Furthermore, the induction of IE gene expression, 413 whilst essential for initiating reactivation, does not, by itself, dictate that infectious virus will be 414 produced. It is highly likely that a number of viral gene products and cellular interactions are 415 important for driving HCMV reactivation through early and late gene expression and ultimately to 416 the production of infectious virus. Consistent with this are studies performed on both experimental 417 and natural latency. In the very first reports studying HCMV latency ex vivo from in vitro 418 differentiated monocytes both IE and early gene expression was detectable [19] . Similarly, the 419 transfection of IE proteins into latently infected THP1 cells again resulted in the induction of early 420 gene expression [20] . However, the recovery of infectious virus was not observed in either system. 421
Indeed, the first description of the reactivation of infectious virus ex vivo from CD14+ monocytes 422 was reported using a cytokine cocktail derived from allogeneically stimulated T cells [78] . This 423 suggested that signalling events associated with both differentiation and inflammation are key to 424 efficient HCMV reactivation. Arguably, cell differentiation (at least within the myeloid lineage) 425 remains the major determinant of HCMV reactivation and that inflammation increases the efficacy 426 of the reactivation phenotype. Indeed, more recent studies suggest that the key inflammatory 427 mediator IL-6 has multiple effects on HCMV reactivation ranging from increased IE gene expression, 428 less abortive reactivation events and, ultimately, more efficient reactivation of infectious progeny -429 in part, by altering the particle to plaque forming unit ratio of the progeny virus [68] chronically infected mice had a dramatic impact on the level of reactivation in the murine model 435 [116] . Elucidating the precise mechanism of action of systemic interferon is clearly hard to dissect. 436
Interferon-beta has a direct impact on the replication of both MCMV and HCMV in vitro (for review 437 see [117, 118] ) -as well as many other viruses -and thus the effects observed could be due to a 438 whole multitude of interferon-induced effects. The authors hypothesised that the well known 439 interferon induced accumulation of nuclear domain 10 bodies could be a key factor in the observed 440 phenotype [116] . However, failing a PML KO mouse there was no direct evidence for this phenotype, 441 which could potentially be a combination of anti-viral effects associated with interferon activity. 442
Furthermore, we note a recent study of the experimental infection of CD14+ monocytes which 443 suggested that latent HCMV disabled aspects of the JAK/STAT pathway which would render them 444 less sensitive to direct effects of interferons if the observations were to be extrapolated to HCMV 445 [119] . Nevertheless, what the mouse model does inform is that the complex interplay between the 446 latent cell and the extracellular environment driven by the host will be a key regulator of the latent 447 phenotype. 448
449
If we consider the transition from viral latency to reactivation analogous to pushing a rock up a hill 450 then the more factors that favour reactivation will push the rock towards the precipice of infectious 451 virus production. Countering these effects will be cellular (and viral) responses that are providing 452 resistance to progress and, ultimately, it is the dynamic changes in the activity of these processes 453 which decide the final outcome. 454
455
Concluding remarks 456
The control of HCMV latency and reactivation remains a complex problem. experimental system employed to identify them [28, 29, 31, 33] . More importantly, the expression 482 of viral transcripts in natural latency also displays a level of heterogeneity which, again, appears to 483 be dependent on the haematopoietic cell type analysed [19, 33, 36, 40] . Furthermore, these 484 analyses always represent population analyses yet it is possible that, as described for the gamma 485 herpes viruses, that different patterns of latent viral gene expression occur even within these 486 populations. We noted that in a recent study defining a strategy to remove latently infected cells 487 through the targeting of a UL138 associated function the data suggest that the elimination of the 488 HCMV infected cells was never complete [121] . This could of course be due to the efficacy of 489 vincristine but alternatively, could suggest a latent population with a different transcriptional profile. 490
Additonally, latent gene expression is predicted to be dictated by the cellular transcriptional milieu 491 thus if multiple sites of cellular latency exist (i.e. neuronal versus endothelial versus haematopoietic) 492 then the latent transcriptional profile could be markedly different. This seems highly plausible given 493 that transcriptional differences are observed within the different cell populations of the 494 haematopoietic lineage alone. 495
496
As we begin to unravel the complexity of HCMV latency and reactivation, the use of the phrase 497 'quiescent infection' interchangeably with 'latency' is increasingly becoming a misnomer that fails to 498 do justice to the increasingly complex and active regulation of the latent lifecycle of, and by, HCMV. 499 500 
